跳至主要内容
临床试验/IRCT20240527061915N1
IRCT20240527061915N1招募中3 期

Comparing the prophylactic effect of adding magnesium to Metoral in reducing atrial fibrillation after coronary artery bypass graft surgery

Arak University of Medical Sciences0 个研究点目标入组 102 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
102

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 75 years(—)
性别
All

入选标准

  • All CABG candidate patients referred to Amirul Mominin Arak Hospital
  • All patients candidates for elective operations
  • The age of patients between 35-75 years
  • All patients are candidates for CABG only
  • All patients who are operated with that pump
  • All patients with informed consent to participate in this study
  • The average duration of surgery is maximum 7 hours
  • All patients who do not have heart valve repair surgery with CABG
  • ASA?,? patients
  • Patients who are not allergic to Metoral-Magnesium
  • All patients who have acid-base disorders resistant to treatment before surgery

排除标准

  • Patients who suffer cardio-respiratory arrest during surgery
  • Patients who do not agree to continue the study or cooperate
  • All CABG candidate patients who require valve repair during surgery
  • All patients who, after the induction of anesthesia, the surgeon decides to perform surgery with the pump OFF
  • All patients who have acid-base disorders resistant to treatment before surgery

研究者

相似试验